Cleerly, Inc.

About Cleerly, Inc.

Cleerly uses AI-powered coronary CT angiography analysis to quantify atherosclerotic plaque and stenosis, enabling clinicians to identify, stage, and track heart disease earlier and more precisely than traditional stress testing or catheterization. The company offers cloud-based software and clinical services that integrate with existing imaging workflows, providing standardized, reproducible reports that guide preventive cardiology and personalized treatment decisions. Cleerly partners with health systems, imaging centers, and payers to improve cardiovascular risk assessment and reduce myocardial infarction rates.